 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- | KA34 / Scripps Research Institute, California Institute for Regenerative Medicine
Trial completion: A Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of KA34 in Subjects With Knee Osteoarthritis (clinicaltrials.gov) - Apr 30, 2020
P1, N=60, Completed, Sponsor: Calibr, a division of Scripps Research
Active, not recruiting --> Completed
- | KA34 / Scripps Research Institute, California Institute for Regenerative Medicine
Trial primary completion date: A Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of KA34 in Subjects With Knee Osteoarthritis (clinicaltrials.gov) - Jan 23, 2020
P1, N=60, Active, not recruiting, Sponsor: Calibr, a division of Scripps Research
Active, not recruiting --> Completed Trial primary completion date: Nov 2019 --> Apr 2020
- | KA34 / Scripps Research Institute, California Institute for Regenerative Medicine
Enrollment closed: A Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of KA34 in Subjects With Knee Osteoarthritis (clinicaltrials.gov) - Nov 15, 2019
P1, N=60, Active, not recruiting, Sponsor: Calibr, a division of Scripps Research
Trial primary completion date: Nov 2019 --> Apr 2020 Recruiting --> Active, not recruiting
- | KA34 / Scripps Research Institute, California Institute for Regenerative Medicine
Trial completion date, Trial primary completion date: A Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of KA34 in Subjects With Knee Osteoarthritis (clinicaltrials.gov) - Jul 24, 2019
P1, N=60, Recruiting, Sponsor: Calibr, a division of Scripps Research
Recruiting --> Active, not recruiting Trial completion date: Feb 2020 --> Jun 2020 | Trial primary completion date: Sep 2019 --> Dec 2019
- | KA34 / Scripps Research Institute, California Institute for Regenerative Medicine
Enrollment open, Trial completion date, Trial initiation date, Trial primary completion date: A Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of KA34 in Subjects With Knee Osteoarthritis (clinicaltrials.gov) - Mar 29, 2018
P1, N=60, Recruiting, Sponsor: California Institute for Biomedical Research
Trial completion date: Feb 2020 --> Jun 2020 | Trial primary completion date: Sep 2019 --> Dec 2019 Not yet recruiting --> Recruiting | Trial completion date: May 2019 --> Feb 2020 | Initiation date: Jan 2018 --> Apr 2018 | Trial primary completion date: May 2019 --> Sep 2019
- | KA34 / Scripps Research Institute, California Institute for Regenerative Medicine
Trial initiation date: A Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of KA34 in Subjects With Knee Osteoarthritis (clinicaltrials.gov) - Aug 22, 2017
P1, N=60, Not yet recruiting, Sponsor: California Institute for Biomedical Research
Not yet recruiting --> Recruiting | Trial completion date: May 2019 --> Feb 2020 | Initiation date: Jan 2018 --> Apr 2018 | Trial primary completion date: May 2019 --> Sep 2019 Initiation date: Oct 2017 --> Jan 2018
- | KA34 / Scripps Research Institute, California Institute for Regenerative Medicine
New P1 trial: A Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of KA34 in Subjects With Knee Osteoarthritis (clinicaltrials.gov) - Apr 27, 2017
P1, N=60, Not yet recruiting, Sponsor: California Institute for Biomedical Research